University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOS

Phase 2

Completed

Conditions: Autistic Disorder
Asperger Syndrome
Anxiety Disorders

Interventions: Behavioral: Cognitive-behavioral therapy

First Posted Date: 2006-01-23

Last Posted Date: 2012-04-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 20

Registration Number: NCT00280670

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Behavioral Treatment of Insomnia in Aging

Not Applicable

Completed

Conditions: Aging
Insomnia

Interventions: Behavioral: Cognitive Behavior Therapy (CBT)
Behavioral: Tai Chi Chih (TCC)
Behavioral: Sleep Seminar (SS)

First Posted Date: 2006-01-20

Last Posted Date: 2012-07-11

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 123

Registration Number: NCT00280020

Locations: 🇺🇸
Cousins Center for Psychoneuroimmunology, UCLA Neuropsychiatric Institute, Los Angeles, California, United States

Characteristics of Episodic Ataxia Syndrome

Completed

Conditions: Episodic Ataxia Syndrome
Cerebellar Diseases

First Posted Date: 2005-12-19

Last Posted Date: 2023-05-15

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 39

Registration Number: NCT00266760

Locations: 🇬🇧
Institute of Neurology, Center for Neuromuscular Disease, Queen Square, London, United Kingdom
🇨🇦
London Health Sciences Centre, London, Ontario, Canada
🇺🇸
Reed Neurological Research Center, UCLA, Los Angeles, California, United States

and more 3 locations

Transitional Case Management Study

Phase 3

Completed

Conditions: Substance-Related Disorders

First Posted Date: 2005-12-12

Last Posted Date: 2016-11-18

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 812

Registration Number: NCT00264329

Locations: 🇺🇸
National Development and Research Institutes, Inc. (NDRI), New York, New York, United States
🇺🇸
Connecticut Department of Mental Health and Addiction Services, Hartford, Connecticut, United States
🇺🇸
University of Kentucky, Lexington, Kentucky, United States

and more 1 locations

Constructing an Insulin-Like Growth Factor-based Prediction Model

Terminated

Conditions: Idiopathic Short Stature
Growth Hormone Deficiency
Small for Gestational Age

First Posted Date: 2005-12-08

Last Posted Date: 2014-12-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT00263445

Locations: 🇺🇸
UCLA Pediatric Endocrinology, Los Angeles, California, United States

Effects of Thymectomy During Cardiothoracic Surgery

Completed

Conditions: Thymectomy and Cardiothoracic Surgery

First Posted Date: 2005-12-07

Last Posted Date: 2016-08-24

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 124

Registration Number: NCT00263120

Locations: 🇺🇸
UCLA Adult Congenital Heart Disease Clinic, Los Angeles, California, United States

Prometa Pharmacotherapy for Methamphetamine Dependence

Phase 2

Completed

Conditions: Drug Abuse
Drug Dependence

Interventions: Drug: Placebo
Drug: Prometa

First Posted Date: 2005-12-01

Last Posted Date: 2016-01-22

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 120

Registration Number: NCT00260481

Locations: 🇺🇸
UCLA Integrated Substance Abuse Programs, Los Angeles, California, United States

Cysteine Supplementation in Critically Ill Neonates

Phase 2

Conditions: Sepsis
Bronchopulmonary Dysplasia
Necrotizing Enterocolitis
Retinopathy of Prematurity
Systemic Inflammatory Response Syndrome

Interventions: Dietary Supplement: Parenteral cysteine-HCl supplementation
Dietary Supplement: Placebo - added premasol

First Posted Date: 2005-11-15

Last Posted Date: 2010-02-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 108

Registration Number: NCT00254176

Locations: 🇺🇸
UCLA Medical Center, Mattel Childrens Hospital, Los Angeles, California, United States

Behavioral Therapy Development for Methamphetamine Abuse

Phase 1

Terminated

Conditions: Depression
Drug Abuse
Sexually Transmitted Diseases

First Posted Date: 2005-11-11

Last Posted Date: 2016-01-27

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT00252434

Locations: 🇺🇸
UCLA Center for Clinical AIDS Research and Education (CARE) Clinic, Los Angeles, California, United States

A Study to Test the Pain-relieving Effect of Laughing Gas in Infants

Phase 3

Withdrawn

Conditions: Analgesic Affect

First Posted Date: 2005-11-08

Last Posted Date: 2017-02-17

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT00250692

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy